Abeona Therapeutics names Mohamad Tabrizi as chief business officer Dec 15, 2025 07:31AM
Abeona Therapeutics® Announces Appointment of Mohamad Tabrizi as Chief Business Officer Dec 15, 2025 07:30AM
Abeona Therapeutics (ABEO) PT Lowered to $16 at RBC Capital Aug 13, 2019 06:31AM
Abeona Therapeutics Announces Participation in Upcoming Investor Conferences May 7, 2019 04:15PM
Abeona Therapeutics Announces Participation in Upcoming Investor Conferences May 7, 2019 04:15PM


Mar 20, 2019 06:27AM Abeona Therapeutics (ABEO) PT Lowered to $23 at RBC Capital
Feb 21, 2018 08:45AM Abeona Therapeutics Announces Upcoming Conference Participation
Feb 21, 2018 08:45AM Abeona Therapeutics Announces Upcoming Conference Participation
Jan 23, 2018 05:22AM RBC Capital Assumes Abeona Therapeutics (ABEO) at Outperform, Sees Catalyst Rich 2018 Offering Upside
Oct 19, 2017 09:39AM Abeona Announces Closing of $92 Million Underwritten Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares
Oct 17, 2017 05:44AM Abeona Therapeutics (ABEO) Prices 5M Share Common Offering at $16/Sh
Oct 16, 2017 09:45PM Abeona Therapeutics Announces Pricing of Public Offering of Common Stock
Sep 14, 2017 04:31PM RBC Capital Starts Abeona Therapeutics (ABEO) at Outperform
Feb 21, 2017 07:48AM Abeona Therapeutics to Present at the 2017 RBC Capital Markets Global Healthcare Conference and 3rd Annual CRISPR Congress